Join the club for FREE to access the whole archive and other member benefits.

Timothy (Tim) Cash

Chief Scientific Officer at Senolytic Therapeutics.

Tim has extensive experience in aging and age-related diseases such as cancer and diabetes. He has carried out multiple genetic and drug screens to identify novel diabetes and cancer therapeutics during his academic career which has inspired him to pursue a career in industry. Tim has a Ph.D. in Cell and Molecular Biology at the University of Pennsylvania and outstanding postdoctoral experience at the prestigious Spanish National Cancer Center (CNIO) in Madrid, Spain.

Visit website:

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Senolytic Therapeutics (Senolytx) - Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Timothy (Tim) Cash News

Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed


Genes that help you live to 100

New Scientist - 30-Dec-2015

Searching the genomes of centenarians these genes are most clearly associated with lifespan. 20 ...